Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinmaitong for endothelial function in hypertension
ChiCTR2000030428Phase 4Not yet recruiting
- Sponsor
- Jiangmen Central Hospital
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of xinmaitong in essential hypertension (3 arms), sponsored by Jiangmen Central Hospital. Primary endpoints: Endothelial function and Blood pressure. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
xinmaitong
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2000030428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030428.